Decreased ILC2 frequency in PBMC during SLIT treatment
There was no significant difference in the level of ILC2 between the SLIT group and the control group at the baseline period (0.118 ± 0.036 vs 0.116 ± 0.042, After completing the 1- and 2-year treatment period, the significant downregulation of ILC2 frequency in PBMCs from AR donor. *